LIFNanoRX, a venture that targets multiple sclerosis (MS), is named Most Promising Nanomedicine Project at the annual BIO-Europe conference. LIFNano is currently on the Accelerate Cambridge programme run by the Cambridge Judge Entrepreneurship Centre, and previously was supported by the Cambridge Social Ventures programme at the Cambridge Centre for Social Innovation at Cambridge Judge.
Read the full article [nano-magazine.com]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments